Announcements Trials
Browse Landscape

Phase

Phase 2 166Phase 1 70Phase 1/2 35Phase 3 33Phase NA 18Phase EARLY_PHASE1 6Phase 2/3 4Phase 4 3

Status

Unknown 3Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia 11Lymphoma 10Breast Neoplasms 10Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 5Multiple Myeloma 4Graft vs Host Disease 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Biphenotypic, Acute 3Anemia, Refractory, with Excess of Blasts 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2Leukemia, Myelomonocytic, Chronic 2Hematologic Neoplasms 2Congenital Abnormalities 2Burkitt Lymphoma 2Anemia, Refractory 2Virus Diseases 1Triple Negative Breast Neoplasms 1

Interventions

Dexamethasone 8daratumumab 5Lenalidomide 5Bortezomib 5Thalidomide 4Cyclophosphamide 4carfilzomib 2Melphalan 2Calcium Dobesilate 2trametinib 1tanespimycin 1pomalidomide 1fludarabine 1dabrafenib 1cobimetinib 1Whole-Body Irradiation 1Vemurafenib 1Stem Cell Transplantation 1Rivaroxaban 1Mesna 1MAGEA3 protein, human 1Lenograstim 1Human Growth Hormone 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Busulfan 1Bone Marrow Transplantation 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Multiple Myeloma × Cyclophosphamide × Clear all
NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

National University Hospital, Singapore

Phase 2/3 Unknown
20 enrolled
Plasma cell

Multiple Myeloma

NCT00177047 2021-11-09

Autologous Transplant for Multiple Myeloma

Masonic Cancer Center, University of Minnesota

Phase 2/3 Completed
363 enrolled 25 charts
Plasma cell

Multiple Myeloma

NCT03385096 2020-02-25

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
122 enrolled
Plasma cell

Multiple Myeloma

NCT02270307 2014-10-21

MSC-CY

National Research Center for Hematology, Russia

Phase 2/3 Unknown
40 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡